Thrombotic thrombocytopenic purpura in metastatic carcinoma of the breast.

We present a case of a 52-year-old woman with thrombotic thrombocytopenic purpura associated with progressive metastatic adenocarcinoma of the breast. The patient received plasma exchange therapy. Thrombocytopenic purpura resolved 2 months after discontinuation of plasma exchange while the patient received chemotherapy. After 3 more months, a fulminant relapse of the thrombocytopenic purpura developed, and there were signs of tumor progression. She died despite adequate treatment. We conclude that effective treatment of the underlying tumor can be crucial to control cancer-associated thrombocytopenic purpura.
AuthorsN von Bubnoff, M Sandherr, F Schneller, C Peschel
JournalAmerican journal of clinical oncology (Am J Clin Oncol) Vol. 23 Issue 1 Pg. 74-7 (Feb 2000) ISSN: 0277-3732 [Print] UNITED STATES
PMID10683084 (Publication Type: Case Reports, Journal Article)
  • Adenocarcinoma (complications, secondary, therapy)
  • Breast Neoplasms (complications, pathology, therapy)
  • Female
  • Humans
  • Middle Aged
  • Purpura, Thrombotic Thrombocytopenic (etiology, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: